A. Masada

Hypolipidemic effect of ethyl all-cis-5,8,11,14,17-eicosapentaenoate (EPA-E) in rats.

Y. Saito, T. Yano, K. Mizuguchi, 1992, Japanese journal of pharmacology.

Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) Plus Gemcitabine in Patients with Advanced Solid Tumors

N. Sharma, J. Grilley-Olson, L. Bazhenova, 2017, Clinical Cancer Research.

NC-6004 Phase I study in combination with gemcitabine for advanced solid tumors and population PK/PD analysis

A. Ohtsu, T. Hamaguchi, Y. Shimada, 2017, Cancer Chemotherapy and Pharmacology.

Ethyl all-cis-5,8,11,14,17-icosapentaenoate modifies the biochemical properties of rat very low-density lipoprotein.

Y. Saito, T. Yano, K. Mizuguchi, 1993, European journal of pharmacology.

Mechanism of the lipid-lowering effect of ethyl all-cis-5,8,11,14,17-icosapentaenoate.

Y. Saito, T. Yano, K. Mizuguchi, 1993, European journal of pharmacology.

Effects of synthetic omega-conotoxin on the contractile responses of segments of rat ileum, stomach fundus and uterus and guinea pig taenia coli.

S. Ichida, A. Masada, T. Hata, 1988, Japanese journal of pharmacology.

Effects of GTP analogues and activation of endogenous protein kinases on photoaffinity labeling with [3H](+)PN200-110 of crude membranes from rat heart and brain.

T. Wada, S. Ichida, H. Kishino, 1992, Biochimica et biophysica acta.